Eric Lefkofsky Is on a Task to Discover the Cure for Cancer Eric Lefkofsky Is on a Task to Discover the Cure for Cancer

 

We are fortunate how technology has benefited our federal agencies such as the National Cancer Institute, which is busy in cancer research. And, according to some study cases — 2010 through 2014 — men and women in America are at a 38%-or-more risk of having cancer in life. Throughout the healthcare field, modern technology has advanced our computer systems. Thus, doctors have used improved skills in caring for cancer patients.

Even so, Eric Lefkofsky has had no illnesses or symptoms of the disease. However, through an analysis procedure, the medic diagnosed Lefkofsky’s wife with breast cancer. Over that experience, he discovered a disadvantage of the healthcare process. Now, Eric Lefkofsky is on a mission to find a cure for cancer. For starters, he noticed the massive amount of collected data during each patient visit. Both doctor and nurse carefully gathered this information.

Even so, he simultaneously recognized the failure in how the clinics used data collection and the possibility of development for cancer treatment. And the flaw is the primary reason he co-founded Tempus. What’s more, Eric Lefkofsky and Tempus are coming up with an arrangement which allows a patient’s clinical data to include molecular information. They have realized changes in treatment and the reactions to medication, greatly contrasting.

Therefore, no two cases are the same. So, we’re looking at the genome process – which has been around for a while. It has reached a surprising development in the use of science and technology. Through this course of action, we used molecular data collected in personal genome discovering. Since 2003, the human DNA project has cost millions of dollars for those who used it.

The Tempus Company are promoting their efforts to apply the usual sequencing procedure. Thus, this strategic endeavor is for the sake of battling cancer on cellular and molecular degrees. However, the physicians used genome sequencing to gather entire data collection. For many doctors, the data collection will be learning tools they will use to provide equal treatment to each person living with cancer.

So, the Tempus Company certifies physicians to provide custom-made cancer care through its diagnostic and machine information platform. The Michigan native — Eric Lefkofsky — has invested over hundred million dollars into Tempus. Also, he is a steadfast enemy to cancer, and the Company is one of his best ways to ensure cancer patients receive customize medical treatment. On top of that, Lefkofsky is taking part in the technology industry and the philanthropic area.

What’s more, both he and his wife Liz are community activists in Chicago. As well, they are running the Lefkofsky Family Foundation to contribute much to the needs of community organizations.

Tagged

Leave a Reply

Your email address will not be published. Required fields are marked *